What is MDCXW's health score?

Medicus Pharma Ltd. (MDCXW) has a TradeApes health score of 37 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MDCXW's estimated fair value?

Based on our 5-year discounted cash flow model, Medicus Pharma Ltd.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is MDCXW undervalued or overvalued?

Our model currently rates MDCXW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MDCXW... Refresh in a moment for the full analysis.

Medicus Pharma Ltd. (MDCXW)

Healthcare Fair Value High weak

Updated: 2026-04-21

TradeApes Score

reduce

Financial Strength

35 Weak

Operating Trend

30 Weak

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

65 Healthy

Key Findings

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.